• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从大型酵母展示文库中筛选高亲和力异源二聚体抗原结合 Fc 片段。

Selection of High-Affinity Heterodimeric Antigen-Binding Fc Fragments from a Large Yeast Display Library.

机构信息

Christian Doppler Laboratory for Innovative Immunotherapeutics, Institute of Molecular Biology, Department of Biotechnology, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria.

出版信息

Methods Mol Biol. 2023;2681:131-159. doi: 10.1007/978-1-0716-3279-6_9.

DOI:10.1007/978-1-0716-3279-6_9
PMID:37405647
Abstract

Antigen-binding Fc (Fcab™) fragments, where a novel antigen binding site is introduced by the mutagenesis of the C-terminal loops of the C3 domain, function as parts of bispecific IgG-like symmetrical antibodies when they replace their wild-type Fc. Their homodimeric structure typically leads to bivalent antigen binding. In particular, biological situations monovalent engagement, however, would be preferred, either for avoiding agonistic effects leading to safety issues, or the attractive option of combining a single chain (i.e., one half) of an Fcab fragment reactive with different antigens in one antibody. We present the strategies for construction and selection of yeast libraries displaying heterodimeric Fcab fragments and discuss the effects of altered thermostability of the basic Fc scaffold and novel library designs that lead to isolation of highly affine antigen binding clones.

摘要

抗原结合 Fc(FcabTM)片段,通过对 C3 结构域 C 端环的突变引入新的抗原结合位点,当取代其野生型 Fc 时,可作为双特异性 IgG 样对称抗体的一部分。它们的同源二聚体结构通常导致二价抗原结合。特别是,在某些生物学情况下,单价结合可能更受欢迎,无论是为了避免导致安全问题的激动作用,还是为了将与不同抗原反应的 Fcab 片段的单链(即一半)组合在一个抗体中的诱人选择。我们介绍了构建和选择展示异源二聚体 Fcab 片段的酵母文库的策略,并讨论了改变基本 Fc 支架的热稳定性和导致分离高亲和力抗原结合克隆的新型文库设计的影响。

相似文献

1
Selection of High-Affinity Heterodimeric Antigen-Binding Fc Fragments from a Large Yeast Display Library.从大型酵母展示文库中筛选高亲和力异源二聚体抗原结合 Fc 片段。
Methods Mol Biol. 2023;2681:131-159. doi: 10.1007/978-1-0716-3279-6_9.
2
Yeast Surface Display and Cell Sorting of Antigen-Binding Fc Fragments.酵母表面展示与抗原结合Fc片段的细胞分选
Methods Mol Biol. 2019;1923:287-308. doi: 10.1007/978-1-4939-9024-5_13.
3
Designing Fcabs: well-expressed and stable high affinity antigen-binding Fc fragments.设计Fcabs:表达良好且稳定的高亲和力抗原结合Fc片段。
Protein Eng Des Sel. 2017 Sep 1;30(9):657-671. doi: 10.1093/protein/gzx042.
4
Engineering of Immunoglobulin Fc Heterodimers Using Yeast Surface-Displayed Combinatorial Fc Library Screening.利用酵母表面展示组合Fc文库筛选技术构建免疫球蛋白Fc异源二聚体
PLoS One. 2015 Dec 16;10(12):e0145349. doi: 10.1371/journal.pone.0145349. eCollection 2015.
5
Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties.在免疫球蛋白恒定域的结构环中引入抗原结合位点:具有工程化 HER2/neu 结合位点和抗体特性的 Fc 片段。
Protein Eng Des Sel. 2010 Apr;23(4):289-97. doi: 10.1093/protein/gzq005. Epub 2010 Feb 11.
6
Engineered IgG1-Fc--one fragment to bind them all.工程化IgG1-Fc——一种能结合所有物质的片段。
Immunol Rev. 2016 Mar;270(1):113-31. doi: 10.1111/imr.12385.
7
Directed evolution of Her2/neu-binding IgG1-Fc for improved stability and resistance to aggregation by using yeast surface display.利用酵母表面展示技术对 Her2/neu 结合 IgG1-Fc 进行定向进化,以提高稳定性和抗聚集能力。
Protein Eng Des Sel. 2013 Apr;26(4):255-65. doi: 10.1093/protein/gzs102. Epub 2012 Dec 23.
8
Construction of pH-sensitive Her2-binding IgG1-Fc by directed evolution.通过定向进化构建pH敏感的Her2结合IgG1-Fc。
Biotechnol J. 2014 Aug;9(8):1013-22. doi: 10.1002/biot.201300483.
9
Fcab-HER2 Interaction: a Ménage à Trois. Lessons from X-Ray and Solution Studies.Fcab与HER2的相互作用:三方关系。来自X射线和溶液研究的经验教训。
Structure. 2017 Jun 6;25(6):878-889.e5. doi: 10.1016/j.str.2017.04.014. Epub 2017 May 18.
10
Creating stable stem regions for loop elongation in Fcabs - insights from combining yeast surface display, in silico loop reconstruction and molecular dynamics simulations.为Fcabs中的环延伸创建稳定的茎区——结合酵母表面展示、计算机辅助环重建和分子动力学模拟的见解
Biochim Biophys Acta. 2014 Sep;1844(9):1530-40. doi: 10.1016/j.bbapap.2014.04.020. Epub 2014 May 2.

引用本文的文献

1
Cattle-derived knob paratopes grafted onto peripheral loops of the IgG1 Fc region enable the generation of a novel symmetric bispecific antibody format.牛源 knob 互补决定区被嫁接到 IgG1 Fc 区域的外周环上,能够产生一种新型的对称双特异性抗体形式。
Front Immunol. 2023 Oct 24;14:1238313. doi: 10.3389/fimmu.2023.1238313. eCollection 2023.

本文引用的文献

1
Mosunetuzumab: First Approval.莫舒替尼单抗:首次批准。
Drugs. 2022 Jul;82(11):1229-1234. doi: 10.1007/s40265-022-01749-5.
2
Teclistamab in Relapsed or Refractory Multiple Myeloma.特卡昔单抗治疗复发或难治性多发性骨髓瘤。
N Engl J Med. 2022 Aug 11;387(6):495-505. doi: 10.1056/NEJMoa2203478. Epub 2022 Jun 5.
3
Bispecific mAb Antibodies Targeting CD59 Enhance the Complement-Dependent Cytotoxicity Mediated by Rituximab.双特异性 mAb 抗体靶向 CD59 增强利妥昔单抗介导的补体依赖性细胞毒性。
Int J Mol Sci. 2022 May 6;23(9):5208. doi: 10.3390/ijms23095208.
4
Trispecific antibodies produced from mAb pairs by controlled Fab-arm exchange.通过 Fab 臂交换控制由单抗对产生的三特异性抗体。
Biol Chem. 2022 Jan 31;403(5-6):509-523. doi: 10.1515/hsz-2021-0376. Print 2022 Apr 26.
5
Structural design of tetravalent T-cell engaging bispecific antibodies: improve developability by engineering disulfide bonds.四价T细胞衔接双特异性抗体的结构设计:通过工程化二硫键改善可开发性
J Biol Eng. 2021 Jun 29;15(1):18. doi: 10.1186/s13036-021-00272-7.
6
Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseases.法替西单抗:一种针对 Tie-2/血管生成素途径和 VEGF-A 的研究性药物,用于治疗视网膜疾病。
Expert Opin Investig Drugs. 2021 Mar;30(3):193-200. doi: 10.1080/13543784.2021.1879791. Epub 2021 Feb 4.
7
FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, Exhibits Low Toxicity and Antitumor Activity in Colorectal Cancer Models.FS222,一种CD137/PD-L1四价双特异性抗体,在结直肠癌模型中显示出低毒性和抗肿瘤活性。
Clin Cancer Res. 2020 Aug 1;26(15):4154-4167. doi: 10.1158/1078-0432.CCR-19-2958. Epub 2020 Apr 28.
8
FS118, a Bispecific Antibody Targeting LAG-3 and PD-L1, Enhances T-Cell Activation Resulting in Potent Antitumor Activity.FS118,一种靶向 LAG-3 和 PD-L1 的双特异性抗体,增强 T 细胞激活,从而产生强大的抗肿瘤活性。
Clin Cancer Res. 2020 Jul 1;26(13):3333-3344. doi: 10.1158/1078-0432.CCR-19-3548. Epub 2020 Apr 16.
9
CD137/OX40 Bispecific Antibody Induces Potent Antitumor Activity that Is Dependent on Target Coengagement.CD137/OX40 双特异性抗体诱导有效的抗肿瘤活性,该活性依赖于靶标共结合。
Cancer Immunol Res. 2020 Jun;8(6):781-793. doi: 10.1158/2326-6066.CIR-19-0798. Epub 2020 Apr 9.
10
CD3 bispecific antibody-induced cytokine release is dispensable for cytotoxic T cell activity.CD3 双特异性抗体诱导的细胞因子释放对于细胞毒性 T 细胞的活性并非必需。
Sci Transl Med. 2019 Sep 4;11(508). doi: 10.1126/scitranslmed.aax8861.